World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
43606
World Ranking
10693
National Ranking
5496

Overview

Tito Fojo is affiliated with Columbia University in the United States and has a research focus primarily within the field of medicine, with particular emphasis on oncology. Their extensive publication record reflects contributions to oncology, pulmonary and respiratory medicine, cancer research, radiology, nuclear medicine and imaging, and surgery.

Their research emphasis covers a variety of main topics including:

  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Colorectal Cancer Treatments and Studies
  • Prostate Cancer Treatment and Research
  • Neuroblastoma Research and Treatments

Some recent papers authored or co-authored by Tito Fojo include:

  • "Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis," 2022, JAMA Oncology
  • "Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement," 2023, Nature Reviews Endocrinology
  • "Emerging Therapeutic Implications of STK11 Mutation: Case Series," 2020, The Oncologist
  • "Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation," 2020, Clinical Cancer Research
  • "Inappropriate censoring in Kaplan-Meier analyses," 2021, The Lancet Oncology

Frequently appearing publication venues for their work include:

  • The Oncologist
  • Seminars in Oncology
  • Journal of Clinical Oncology
  • The Lancet Oncology
  • JAMA Network Open

Tito Fojo has collaborated often with several co-authors, including:

  • Susan E. Bates
  • Mengxi Zhou
  • Lawrence H. Schwartz
  • Laurent Dercle
  • Binsheng Zhao

Best Publications

  • Multidrug resistance in cancer: role of ATP–dependent transporters

    Michael M. Gottesman;Tito Fojo;Susan E. Bates

  • Tumour stem cells and drug resistance

    Michael Dean;Tito Fojo;Susan Bates

  • An Information-Intensive Approach to the Molecular Pharmacology of Cancer

    John N. Weinstein;Timothy G. Myers;Patrick M. O'Connor;Stephen H. Friend

  • The Role of ABC Transporters in Clinical Practice

    Gregory D. Leonard;Tito Fojo;Susan E. Bates

  • Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

    Keisuke Miyake;Lyn Mickley;Thomas Litman;Zhirong Zhan

  • Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

    Paraskevi Giannakakou;Dan L. Sackett;Yoon-Koo Kang;Zhirong Zhan

  • Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin

  • Oxaliplatin, Tetraplatin, Cisplatin, and Carboplatin: Spectrum of Activity in Drug-Resistant Cell Lines and in the Cell Lines of the National Cancer Institute's Anticancer Drug Screen Panel

    Olivier Rixe;Waldo Ortuzar;Manuel Alvarez;Ricardo Parker

  • Delivering affordable cancer care in high-income countries

    Richard Sullivan;Jeffrey Peppercorn;Karol Sikora;John Zalcberg

  • A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

    Paraskevi Giannakakou;Rick Gussio;Eva Nogales;Kenneth H. Downing

  • Raf-1/bcl-2 Phosphorylation: A Step from Microtubule Damage to Cell Death

    Mikhail V. Blagosklonny;Paraskevi Giannakakou;Wafik S. El-Deiry;David G. I. Kingston

  • Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways

    Tzu Hao Wang;Hsin Shih Wang;Hidenori Ichijo;Paraskevi Giannakakou

  • Strategies for reversing drug resistance.

    Tito Fojo;Susan Bates

  • Molecular effects of paclitaxel: myths and reality (a critical review).

    Mikhail V. Blagosklonny;Tito Fojo

  • p53 is associated with cellular microtubules and is transported to the nucleus by dynein.

    Paraskevi Giannakakou;Dan L. Sackett;Yvona Ward;Kevin R. Webster

  • How Much Is Life Worth: Cetuximab, Non–Small Cell Lung Cancer, and the $440 Billion Question

    Tito Fojo;Christine Grady

  • Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia

    Zhengping Zhuang;Chunzhang Yang;Felipe Lorenzo;Maria Merino

  • p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription *

    Mikhail V. Blagosklonny;Won G. An;Larisa Y. Romanova;Jane Trepel

  • Cancer Drugs in the United States: Justum Pretium—The Just Price

    Hagop M. Kantarjian;Tito Fojo;Michael Mathisen;Leonard A. Zwelling

  • Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture.

    Tito Fojo;Sham Mailankody;Andrew Lo

Frequent Co-Authors

Susan E. Bates
Susan E. Bates Columbia University
Mikhail V. Blagosklonny
Mikhail V. Blagosklonny Roswell Park Cancer Institute
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
William D. Figg
William D. Figg National Institutes of Health
Karel Pacak
Karel Pacak National Institutes of Health
Wilfred D. Stein
Wilfred D. Stein Hebrew University of Jerusalem
Frank M. Balis
Frank M. Balis Children's Hospital of Philadelphia
Peter L. Choyke
Peter L. Choyke National Institutes of Health
Thomas Litman
Thomas Litman University of Copenhagen
Maria J. Merino
Maria J. Merino National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring ways to enter or advance in healthcare without attending traditional, on-campus programs, there are many flexible online options. Many prospective students start their medical journey with online nursing courses. These provide foundational knowledge and clinical skills, often at lower costs and with greater scheduling flexibility.

For registered nurses seeking career growth, the cheapest rn to bsn program options can help you earn your Bachelor of Science in Nursing online and efficiently. Those interested in leadership, research, or academia may consider online nursing phd programs, which offer advanced education and open doors to policy or faculty roles.

Non-nursing majors looking for a rapid career change can benefit from online direct entry msn programs for non-nursing majors. These programs enable swift entry into advanced nursing careers, even without a prior nursing background.

Pursuing online degrees in healthcare can provide a flexible and affordable pathway into rewarding medical and nursing professions in the USA.

Best Scientists Citing Tito Fojo

Trending Scientists

Recently Published Articles